Open AccessImmune checkpoint inhibitor-related gastrointestinal toxicity in patients with malignancy involving the luminal gastrointestinal tract and its impact on cancer outcomes
Author(s) -
Kevin Yu
Publication year - 2022
Publication title -
annals of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.886
H-Index - 33
eISSN - 1792-7463
pISSN - 1108-7471
DOI - 10.20524/aog.2022.0742
Subject(s) - medicine , gastroenterology , cancer , malignancy , adverse effect , gastrointestinal tract , ulcerative colitis , diarrhea , discontinuation , vedolizumab , disease